EP2970930

DANISCO US INC.
Application Number
EP14722824A
Filing Date
Mar 11, 2014
Status
Patent Maintained As Amended
Nov 5, 2021
Grant Date
Dec 8, 2021
External Links
Slate, Register

Biblio Summary

The patent EP2970930B2 was granted on Dec 8, 2021 by Danisco Us Inc. The patent is currently Patent Maintained As Amended.

The table below shows 1 patent oppositions filed on the patent at EPO, listing each opposing company and filing date. Tracking these filings indicates that the applicant is active in this industry, while opposing companies may be signaling their own interest in competing within the same space. These disputes are essential for insights into competitor actions, patent strategy and emerging technological trends.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

NOVOZYMES A/SJan 17, 2019ADMISSIBLE

The table below shows the patents of Danisco Us Inc. that have been opposed by other companies.

Patent NumberTitleGrant DateOpposition Count
EP2215202Variants Of Bacillus Sp. Ts-23 Alpha-Amylase With Altered PropertiesJan 10, 20241
EP2268804Hemicellulase Enriched Compositions For Enhancing Hydrolysis Of BiomassAug 9, 20231
EP2859097Alpha-Amylase Variants Derived From The Alpha Amylase Of Cytophaga Sp.Amylase (Cspamy2).Mar 8, 20231